Type 2 polynomial hierarchies

Cardiovascular disease and risk factors in persons with type 2 diabetes diagnosed in a large population screening: The Nord-Trondelag Diabetes Study, Norway

Journal of Internal Medicine ◽

10.1046/j.1365-2796.2000.00759.x ◽

2000 ◽

Vol 248 (6) ◽

pp. 492-500 ◽

Cited By ~ 16

Author(s):

T. Claudi ◽

K. Midthjell ◽

J. Holmen ◽

K. Fougner ◽

O. Kruger ◽

...

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Large Population ◽

Population Screening

Download Full-text

Diabète de type 2 : les médicaments hypoglycémiants et leurs risques cardiovasculaires

Bulletin de l Académie Nationale de Médecine ◽

10.1016/s0001-4079(19)30390-5 ◽

2017 ◽

Vol 201 (7-9) ◽

pp. 1209-1225

Author(s):

Bernard Bauduceau ◽

Lyse Bordier

Keyword(s):

Diabète De Type 2

Download Full-text

Les complications du diabète de type 2 exigent une prévention multifactorielle qui passe obligatoirement par un contrôle optimisé de l’équilibre glycémique

Bulletin de l Académie Nationale de Médecine ◽

10.1016/s0001-4079(19)30859-3 ◽

2015 ◽

Vol 199 (7) ◽

pp. 1211-1213 ◽

Cited By ~ 1

Author(s):

Claude Jaffiol ◽

Pierre Godeau

Keyword(s):

Diabète De Type 2

Download Full-text

Does short-term administration of glucagon-like peptide type 2 affect bone mass and markers of bone remodeling in short bowel patients?

Gastroenterology ◽

10.1016/s0016-5085(01)81558-4 ◽

2001 ◽

Vol 120 (5) ◽

pp. A314-A314

Author(s):

K HADERSLEV ◽

P JEPPESEN ◽

B HARTMANN ◽

J THULESEN ◽

J GRAFF ◽

...

Keyword(s):

Bone Mass ◽

Bone Remodeling ◽

Short Term ◽

Short Bowel ◽

Term Administration ◽

Glucagon Like Peptide

Download Full-text

Shiga taxin type 2 but not type 1 induces interleukin-12 expression from peripheral blood mononuclear cells via activated nuclear transcription factor-kB

Gastroenterology ◽

10.1016/s0016-5085(01)81612-7 ◽

2001 ◽

Vol 120 (5) ◽

pp. A324-A324

Author(s):

M TATEWAKI ◽

H NAKAO ◽

H NOGAMI ◽

E HOSHINO ◽

H MOTEGI ◽

...

Keyword(s):

Transcription Factor ◽

Peripheral Blood Mononuclear Cells ◽

Peripheral Blood ◽

Mononuclear Cells ◽

Interleukin 12 ◽

Peripheral Blood Mononuclear ◽

Nuclear Transcription Factor ◽

Blood Mononuclear Cells

Download Full-text

M.530 Elevated ambulatory pulse pressure in patients with type 2 diabetes mellitus

Atherosclerosis ◽

10.1016/s0021-9150(04)90528-x ◽

2004 ◽

Vol 5 (1) ◽

pp. 122-123

Author(s):

R HERMIDA

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Pulse Pressure ◽

Ambulatory Pulse Pressure

Download Full-text

W09.216 Coronary calcification score and conventional cardiovascular risk factors in asymptomatic type 2 diabetic subjects: The predict study

Atherosclerosis ◽

10.1016/s0021-9150(04)90215-8 ◽

2004 ◽

Vol 5 (1) ◽

pp. 50

Author(s):

R ELKELES

Keyword(s):

Risk Factors ◽

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Coronary Calcification ◽

Calcification Score ◽

Predict Study ◽

Type 2 Diabetic

Download Full-text

M.463 Use of rosuvastatin versus atorvastatin in type 2 diabetes mellitus subjects: Results of the uranus study

Atherosclerosis ◽

10.1016/s0021-9150(04)90461-3 ◽

2004 ◽

Vol 5 (1) ◽

pp. 107 ◽

Cited By ~ 1

Author(s):

C BERNE

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus

Download Full-text

M.630 Emerging atherogenic risk factors (CRP, $alpha;TNF, HCYS and LP(a)) in compenssated type 2 diabetics

Atherosclerosis ◽

10.1016/s0021-9150(04)90628-4 ◽

2004 ◽

Vol 5 (1) ◽

pp. 146

Author(s):

J RIOJA

Keyword(s):

Risk Factors ◽

Type 2 Diabetics

Download Full-text

M.479 Prevalence of an altered nocturnal decline of blood pressure in hypertensive patients with type 2 diabetes

Atherosclerosis ◽

10.1016/s0021-9150(04)90477-7 ◽

2004 ◽

Vol 5 (1) ◽

pp. 111

Author(s):

C CALVO

Keyword(s):

Blood Pressure ◽

Type 2 Diabetes ◽

Hypertensive Patients

Download Full-text